nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—CYP1A1—Dacarbazine—melanoma	0.0982	0.339	CbGbCtD
Tretinoin—CYP3A4—Temozolomide—melanoma	0.0547	0.189	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0352	0.121	CbGbCtD
Tretinoin—CYP3A7—Docetaxel—melanoma	0.0352	0.121	CbGbCtD
Tretinoin—CYP3A4—Vemurafenib—melanoma	0.03	0.103	CbGbCtD
Tretinoin—CYP3A5—Docetaxel—melanoma	0.0264	0.091	CbGbCtD
Tretinoin—CYP3A4—Docetaxel—melanoma	0.0103	0.0355	CbGbCtD
Tretinoin—CRABP2—skin epidermis—melanoma	0.00906	0.0897	CbGeAlD
Tretinoin—CRABP1—neck—melanoma	0.0048	0.0475	CbGeAlD
Tretinoin—RARRES1—skin of body—melanoma	0.00419	0.0415	CbGeAlD
Tretinoin—RARRES1—mammalian vulva—melanoma	0.00382	0.0379	CbGeAlD
Tretinoin—RXRG—neck—melanoma	0.00379	0.0376	CbGeAlD
Tretinoin—ALDH1A1—neck—melanoma	0.00361	0.0358	CbGeAlD
Tretinoin—CRABP1—eye—melanoma	0.00357	0.0353	CbGeAlD
Tretinoin—CRABP1—retina—melanoma	0.00354	0.035	CbGeAlD
Tretinoin—CRABP2—eye—melanoma	0.00323	0.032	CbGeAlD
Tretinoin—CRABP1—skin of body—melanoma	0.0031	0.0307	CbGeAlD
Tretinoin—CRABP1—mammalian vulva—melanoma	0.00283	0.028	CbGeAlD
Tretinoin—RXRG—eye—melanoma	0.00282	0.0279	CbGeAlD
Tretinoin—CRABP2—skin of body—melanoma	0.00281	0.0278	CbGeAlD
Tretinoin—ALDH1A1—eye—melanoma	0.00269	0.0266	CbGeAlD
Tretinoin—CRABP2—mammalian vulva—melanoma	0.00256	0.0254	CbGeAlD
Tretinoin—RARG—eye—melanoma	0.00235	0.0233	CbGeAlD
Tretinoin—ALDH1A1—skin of body—melanoma	0.00234	0.0232	CbGeAlD
Tretinoin—RARG—retina—melanoma	0.00233	0.0231	CbGeAlD
Tretinoin—CYP1A1—skin epidermis—melanoma	0.00227	0.0225	CbGeAlD
Tretinoin—ALDH1A1—mammalian vulva—melanoma	0.00213	0.0211	CbGeAlD
Tretinoin—ALDH1A2—head—melanoma	0.0021	0.0208	CbGeAlD
Tretinoin—RARG—skin of body—melanoma	0.00205	0.0203	CbGeAlD
Tretinoin—CRABP1—head—melanoma	0.00203	0.0201	CbGeAlD
Tretinoin—RARRES1—lymph node—melanoma	0.00192	0.019	CbGeAlD
Tretinoin—CYP2C18—mammalian vulva—melanoma	0.00187	0.0186	CbGeAlD
Tretinoin—RARG—mammalian vulva—melanoma	0.00187	0.0185	CbGeAlD
Tretinoin—CRABP2—head—melanoma	0.00183	0.0181	CbGeAlD
Tretinoin—RXRA—head—melanoma	0.00182	0.0181	CbGeAlD
Tretinoin—RARB—head—melanoma	0.00164	0.0162	CbGeAlD
Tretinoin—RXRG—head—melanoma	0.0016	0.0159	CbGeAlD
Tretinoin—ALDH1A1—head—melanoma	0.00153	0.0151	CbGeAlD
Tretinoin—RXRB—head—melanoma	0.00151	0.0149	CbGeAlD
Tretinoin—ALDH1A2—lymph node—melanoma	0.00147	0.0146	CbGeAlD
Tretinoin—RARG—head—melanoma	0.00134	0.0132	CbGeAlD
Tretinoin—RARA—head—melanoma	0.00126	0.0124	CbGeAlD
Tretinoin—RARB—lymph node—melanoma	0.00115	0.0114	CbGeAlD
Tretinoin—ALDH1A1—lymph node—melanoma	0.00107	0.0106	CbGeAlD
Tretinoin—RARG—lymph node—melanoma	0.000935	0.00927	CbGeAlD
Tretinoin—RARA—lymph node—melanoma	0.00088	0.00871	CbGeAlD
Tretinoin—CYP1A1—skin of body—melanoma	0.000704	0.00697	CbGeAlD
Tretinoin—CYP2B6—skin of body—melanoma	0.000684	0.00678	CbGeAlD
Tretinoin—CYP1A1—mammalian vulva—melanoma	0.000642	0.00636	CbGeAlD
Tretinoin—CYP1A1—head—melanoma	0.000459	0.00455	CbGeAlD
Tretinoin—CYP2B6—head—melanoma	0.000446	0.00442	CbGeAlD
Tretinoin—Eye disorder—Temozolomide—melanoma	0.000356	0.00107	CcSEcCtD
Tretinoin—Tinnitus—Temozolomide—melanoma	0.000355	0.00107	CcSEcCtD
Tretinoin—Malaise—Bleomycin—melanoma	0.000354	0.00107	CcSEcCtD
Tretinoin—Flushing—Temozolomide—melanoma	0.000353	0.00106	CcSEcCtD
Tretinoin—Arrhythmia—Carmustine—melanoma	0.000352	0.00106	CcSEcCtD
Tretinoin—Dizziness—Vemurafenib—melanoma	0.00035	0.00105	CcSEcCtD
Tretinoin—Alopecia—Carmustine—melanoma	0.000348	0.00105	CcSEcCtD
Tretinoin—Angiopathy—Temozolomide—melanoma	0.000345	0.00104	CcSEcCtD
Tretinoin—Mental disorder—Carmustine—melanoma	0.000345	0.00104	CcSEcCtD
Tretinoin—Erythema—Carmustine—melanoma	0.000343	0.00103	CcSEcCtD
Tretinoin—Malnutrition—Carmustine—melanoma	0.000343	0.00103	CcSEcCtD
Tretinoin—Cough—Bleomycin—melanoma	0.000343	0.00103	CcSEcCtD
Tretinoin—Chills—Temozolomide—melanoma	0.000341	0.00103	CcSEcCtD
Tretinoin—Dehydration—Docetaxel—melanoma	0.00034	0.00102	CcSEcCtD
Tretinoin—Ill-defined disorder—Dactinomycin—melanoma	0.00034	0.00102	CcSEcCtD
Tretinoin—Anaemia—Dactinomycin—melanoma	0.000338	0.00102	CcSEcCtD
Tretinoin—Vomiting—Vemurafenib—melanoma	0.000336	0.00101	CcSEcCtD
Tretinoin—Alopecia—Temozolomide—melanoma	0.000336	0.00101	CcSEcCtD
Tretinoin—Dry skin—Docetaxel—melanoma	0.000335	0.00101	CcSEcCtD
Tretinoin—Chest pain—Bleomycin—melanoma	0.000334	0.00101	CcSEcCtD
Tretinoin—Myalgia—Bleomycin—melanoma	0.000334	0.00101	CcSEcCtD
Tretinoin—Rash—Vemurafenib—melanoma	0.000334	0.001	CcSEcCtD
Tretinoin—Mental disorder—Temozolomide—melanoma	0.000333	0.001	CcSEcCtD
Tretinoin—Dermatitis—Vemurafenib—melanoma	0.000333	0.001	CcSEcCtD
Tretinoin—Back pain—Carmustine—melanoma	0.000332	0.000997	CcSEcCtD
Tretinoin—Headache—Vemurafenib—melanoma	0.000331	0.000997	CcSEcCtD
Tretinoin—Malnutrition—Temozolomide—melanoma	0.000331	0.000996	CcSEcCtD
Tretinoin—Erythema—Temozolomide—melanoma	0.000331	0.000996	CcSEcCtD
Tretinoin—Discomfort—Bleomycin—melanoma	0.00033	0.000994	CcSEcCtD
Tretinoin—Malaise—Dactinomycin—melanoma	0.00033	0.000994	CcSEcCtD
Tretinoin—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000329	0.000991	CcSEcCtD
Tretinoin—Nasopharyngitis—Docetaxel—melanoma	0.000327	0.000984	CcSEcCtD
Tretinoin—Confusional state—Bleomycin—melanoma	0.000323	0.000972	CcSEcCtD
Tretinoin—Vision blurred—Carmustine—melanoma	0.000323	0.000972	CcSEcCtD
Tretinoin—CYP1A1—lymph node—melanoma	0.000322	0.00319	CbGeAlD
Tretinoin—Tremor—Carmustine—melanoma	0.000321	0.000966	CcSEcCtD
Tretinoin—Anaphylactic shock—Bleomycin—melanoma	0.00032	0.000964	CcSEcCtD
Tretinoin—Oedema—Bleomycin—melanoma	0.00032	0.000964	CcSEcCtD
Tretinoin—Back pain—Temozolomide—melanoma	0.00032	0.000964	CcSEcCtD
Tretinoin—Infection—Bleomycin—melanoma	0.000318	0.000958	CcSEcCtD
Tretinoin—Anaemia—Carmustine—melanoma	0.000317	0.000953	CcSEcCtD
Tretinoin—Dysphagia—Docetaxel—melanoma	0.000316	0.000951	CcSEcCtD
Tretinoin—Agitation—Carmustine—melanoma	0.000315	0.000948	CcSEcCtD
Tretinoin—Nausea—Vemurafenib—melanoma	0.000314	0.000945	CcSEcCtD
Tretinoin—Thrombocytopenia—Bleomycin—melanoma	0.000314	0.000944	CcSEcCtD
Tretinoin—Vision blurred—Temozolomide—melanoma	0.000312	0.000939	CcSEcCtD
Tretinoin—Myalgia—Dactinomycin—melanoma	0.000312	0.000938	CcSEcCtD
Tretinoin—Bronchospasm—Docetaxel—melanoma	0.000311	0.000935	CcSEcCtD
Tretinoin—Tremor—Temozolomide—melanoma	0.00031	0.000934	CcSEcCtD
Tretinoin—Discomfort—Dactinomycin—melanoma	0.000308	0.000927	CcSEcCtD
Tretinoin—Ill-defined disorder—Temozolomide—melanoma	0.000307	0.000925	CcSEcCtD
Tretinoin—Anaemia—Temozolomide—melanoma	0.000306	0.000921	CcSEcCtD
Tretinoin—Anorexia—Bleomycin—melanoma	0.000305	0.000919	CcSEcCtD
Tretinoin—Agitation—Temozolomide—melanoma	0.000304	0.000916	CcSEcCtD
Tretinoin—Hypotension—Bleomycin—melanoma	0.000299	0.000901	CcSEcCtD
Tretinoin—Oedema—Dactinomycin—melanoma	0.000299	0.000899	CcSEcCtD
Tretinoin—Malaise—Temozolomide—melanoma	0.000299	0.000899	CcSEcCtD
Tretinoin—Convulsion—Carmustine—melanoma	0.000297	0.000893	CcSEcCtD
Tretinoin—Infection—Dactinomycin—melanoma	0.000297	0.000893	CcSEcCtD
Tretinoin—Hypertension—Carmustine—melanoma	0.000296	0.00089	CcSEcCtD
Tretinoin—Neutropenia—Docetaxel—melanoma	0.000296	0.000889	CcSEcCtD
Tretinoin—Palpitations—Temozolomide—melanoma	0.000293	0.000881	CcSEcCtD
Tretinoin—Thrombocytopenia—Dactinomycin—melanoma	0.000293	0.00088	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Bleomycin—melanoma	0.000292	0.000878	CcSEcCtD
Tretinoin—Chest pain—Carmustine—melanoma	0.000292	0.000878	CcSEcCtD
Tretinoin—Myalgia—Carmustine—melanoma	0.000292	0.000878	CcSEcCtD
Tretinoin—Anxiety—Carmustine—melanoma	0.000291	0.000875	CcSEcCtD
Tretinoin—Cough—Temozolomide—melanoma	0.000289	0.00087	CcSEcCtD
Tretinoin—Paraesthesia—Bleomycin—melanoma	0.000288	0.000866	CcSEcCtD
Tretinoin—Weight increased—Docetaxel—melanoma	0.000288	0.000866	CcSEcCtD
Tretinoin—Convulsion—Temozolomide—melanoma	0.000287	0.000863	CcSEcCtD
Tretinoin—Weight decreased—Docetaxel—melanoma	0.000286	0.00086	CcSEcCtD
Tretinoin—Hypertension—Temozolomide—melanoma	0.000286	0.00086	CcSEcCtD
Tretinoin—Dyspnoea—Bleomycin—melanoma	0.000286	0.00086	CcSEcCtD
Tretinoin—Anorexia—Dactinomycin—melanoma	0.000285	0.000857	CcSEcCtD
Tretinoin—Pneumonia—Docetaxel—melanoma	0.000284	0.000853	CcSEcCtD
Tretinoin—Confusional state—Carmustine—melanoma	0.000282	0.000849	CcSEcCtD
Tretinoin—Arthralgia—Temozolomide—melanoma	0.000282	0.000848	CcSEcCtD
Tretinoin—Myalgia—Temozolomide—melanoma	0.000282	0.000848	CcSEcCtD
Tretinoin—Infestation NOS—Docetaxel—melanoma	0.000282	0.000848	CcSEcCtD
Tretinoin—Infestation—Docetaxel—melanoma	0.000282	0.000848	CcSEcCtD
Tretinoin—Anxiety—Temozolomide—melanoma	0.000281	0.000845	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00028	0.000843	CcSEcCtD
Tretinoin—Oedema—Carmustine—melanoma	0.00028	0.000842	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000279	0.000841	CcSEcCtD
Tretinoin—Discomfort—Temozolomide—melanoma	0.000279	0.000838	CcSEcCtD
Tretinoin—Decreased appetite—Bleomycin—melanoma	0.000279	0.000838	CcSEcCtD
Tretinoin—Infection—Carmustine—melanoma	0.000278	0.000836	CcSEcCtD
Tretinoin—Acute coronary syndrome—Docetaxel—melanoma	0.000278	0.000836	CcSEcCtD
Tretinoin—Renal failure—Docetaxel—melanoma	0.000277	0.000834	CcSEcCtD
Tretinoin—Neuropathy peripheral—Docetaxel—melanoma	0.000276	0.000831	CcSEcCtD
Tretinoin—Myocardial infarction—Docetaxel—melanoma	0.000276	0.000831	CcSEcCtD
Tretinoin—Dry mouth—Temozolomide—melanoma	0.000276	0.00083	CcSEcCtD
Tretinoin—Stomatitis—Docetaxel—melanoma	0.000275	0.000827	CcSEcCtD
Tretinoin—Pain—Bleomycin—melanoma	0.000274	0.000824	CcSEcCtD
Tretinoin—Conjunctivitis—Docetaxel—melanoma	0.000274	0.000824	CcSEcCtD
Tretinoin—Thrombocytopenia—Carmustine—melanoma	0.000274	0.000824	CcSEcCtD
Tretinoin—Tachycardia—Carmustine—melanoma	0.000273	0.000821	CcSEcCtD
Tretinoin—Confusional state—Temozolomide—melanoma	0.000273	0.00082	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000272	0.000819	CcSEcCtD
Tretinoin—Oedema—Temozolomide—melanoma	0.00027	0.000813	CcSEcCtD
Tretinoin—Anaphylactic shock—Temozolomide—melanoma	0.00027	0.000813	CcSEcCtD
Tretinoin—Infection—Temozolomide—melanoma	0.000269	0.000808	CcSEcCtD
Tretinoin—Anorexia—Carmustine—melanoma	0.000267	0.000802	CcSEcCtD
Tretinoin—Epistaxis—Docetaxel—melanoma	0.000266	0.0008	CcSEcCtD
Tretinoin—Nervous system disorder—Temozolomide—melanoma	0.000265	0.000798	CcSEcCtD
Tretinoin—Thrombocytopenia—Temozolomide—melanoma	0.000265	0.000796	CcSEcCtD
Tretinoin—Feeling abnormal—Bleomycin—melanoma	0.000264	0.000794	CcSEcCtD
Tretinoin—Agranulocytosis—Docetaxel—melanoma	0.000263	0.000791	CcSEcCtD
Tretinoin—Skin disorder—Temozolomide—melanoma	0.000263	0.00079	CcSEcCtD
Tretinoin—Acitretin—ALB—melanoma	0.000262	0.522	CrCbGaD
Tretinoin—Hypotension—Carmustine—melanoma	0.000261	0.000786	CcSEcCtD
Tretinoin—Hyperhidrosis—Temozolomide—melanoma	0.000261	0.000786	CcSEcCtD
Tretinoin—Decreased appetite—Dactinomycin—melanoma	0.00026	0.000782	CcSEcCtD
Tretinoin—Fatigue—Dactinomycin—melanoma	0.000258	0.000775	CcSEcCtD
Tretinoin—Anorexia—Temozolomide—melanoma	0.000258	0.000775	CcSEcCtD
Tretinoin—Pain—Dactinomycin—melanoma	0.000256	0.000769	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Carmustine—melanoma	0.000255	0.000767	CcSEcCtD
Tretinoin—Urticaria—Bleomycin—melanoma	0.000255	0.000766	CcSEcCtD
Tretinoin—Haemoglobin—Docetaxel—melanoma	0.000254	0.000765	CcSEcCtD
Tretinoin—Body temperature increased—Bleomycin—melanoma	0.000253	0.000762	CcSEcCtD
Tretinoin—Haemorrhage—Docetaxel—melanoma	0.000253	0.000761	CcSEcCtD
Tretinoin—Hepatitis—Docetaxel—melanoma	0.000253	0.000761	CcSEcCtD
Tretinoin—Insomnia—Carmustine—melanoma	0.000253	0.000761	CcSEcCtD
Tretinoin—Hypoaesthesia—Docetaxel—melanoma	0.000252	0.000757	CcSEcCtD
Tretinoin—Paraesthesia—Carmustine—melanoma	0.000251	0.000756	CcSEcCtD
Tretinoin—Pharyngitis—Docetaxel—melanoma	0.000251	0.000756	CcSEcCtD
Tretinoin—Urinary tract disorder—Docetaxel—melanoma	0.00025	0.000752	CcSEcCtD
Tretinoin—Dyspnoea—Carmustine—melanoma	0.000249	0.00075	CcSEcCtD
Tretinoin—Oedema peripheral—Docetaxel—melanoma	0.000249	0.00075	CcSEcCtD
Tretinoin—Somnolence—Carmustine—melanoma	0.000249	0.000748	CcSEcCtD
Tretinoin—Urethral disorder—Docetaxel—melanoma	0.000248	0.000746	CcSEcCtD
Tretinoin—Feeling abnormal—Dactinomycin—melanoma	0.000246	0.000741	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Temozolomide—melanoma	0.000246	0.000741	CcSEcCtD
Tretinoin—Insomnia—Temozolomide—melanoma	0.000244	0.000736	CcSEcCtD
Tretinoin—Gastrointestinal pain—Dactinomycin—melanoma	0.000244	0.000735	CcSEcCtD
Tretinoin—Visual impairment—Docetaxel—melanoma	0.000244	0.000734	CcSEcCtD
Tretinoin—Decreased appetite—Carmustine—melanoma	0.000243	0.000732	CcSEcCtD
Tretinoin—Paraesthesia—Temozolomide—melanoma	0.000243	0.00073	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Carmustine—melanoma	0.000242	0.000727	CcSEcCtD
Tretinoin—Dyspnoea—Temozolomide—melanoma	0.000241	0.000725	CcSEcCtD
Tretinoin—Somnolence—Temozolomide—melanoma	0.00024	0.000723	CcSEcCtD
Tretinoin—Alitretinoin—ABCB1—melanoma	0.000239	0.478	CrCbGaD
Tretinoin—Erythema multiforme—Docetaxel—melanoma	0.000239	0.00072	CcSEcCtD
Tretinoin—Pain—Carmustine—melanoma	0.000239	0.00072	CcSEcCtD
Tretinoin—Constipation—Carmustine—melanoma	0.000239	0.00072	CcSEcCtD
Tretinoin—Dyspepsia—Temozolomide—melanoma	0.000238	0.000716	CcSEcCtD
Tretinoin—Eye disorder—Docetaxel—melanoma	0.000236	0.000711	CcSEcCtD
Tretinoin—Abdominal pain—Dactinomycin—melanoma	0.000236	0.000711	CcSEcCtD
Tretinoin—Body temperature increased—Dactinomycin—melanoma	0.000236	0.000711	CcSEcCtD
Tretinoin—Hypersensitivity—Bleomycin—melanoma	0.000236	0.00071	CcSEcCtD
Tretinoin—Decreased appetite—Temozolomide—melanoma	0.000235	0.000707	CcSEcCtD
Tretinoin—Flushing—Docetaxel—melanoma	0.000235	0.000706	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Temozolomide—melanoma	0.000233	0.000702	CcSEcCtD
Tretinoin—Fatigue—Temozolomide—melanoma	0.000233	0.000701	CcSEcCtD
Tretinoin—Constipation—Temozolomide—melanoma	0.000231	0.000695	CcSEcCtD
Tretinoin—Pain—Temozolomide—melanoma	0.000231	0.000695	CcSEcCtD
Tretinoin—Feeling abnormal—Carmustine—melanoma	0.000231	0.000693	CcSEcCtD
Tretinoin—Asthenia—Bleomycin—melanoma	0.00023	0.000692	CcSEcCtD
Tretinoin—Angiopathy—Docetaxel—melanoma	0.00023	0.000691	CcSEcCtD
Tretinoin—Gastrointestinal pain—Carmustine—melanoma	0.000229	0.000688	CcSEcCtD
Tretinoin—Chills—Docetaxel—melanoma	0.000227	0.000683	CcSEcCtD
Tretinoin—Pruritus—Bleomycin—melanoma	0.000227	0.000682	CcSEcCtD
Tretinoin—Arrhythmia—Docetaxel—melanoma	0.000226	0.00068	CcSEcCtD
Tretinoin—Alopecia—Docetaxel—melanoma	0.000224	0.000673	CcSEcCtD
Tretinoin—Feeling abnormal—Temozolomide—melanoma	0.000223	0.00067	CcSEcCtD
Tretinoin—Mental disorder—Docetaxel—melanoma	0.000222	0.000667	CcSEcCtD
Tretinoin—Abdominal pain—Carmustine—melanoma	0.000221	0.000665	CcSEcCtD
Tretinoin—Body temperature increased—Carmustine—melanoma	0.000221	0.000665	CcSEcCtD
Tretinoin—Gastrointestinal pain—Temozolomide—melanoma	0.000221	0.000665	CcSEcCtD
Tretinoin—Malnutrition—Docetaxel—melanoma	0.00022	0.000663	CcSEcCtD
Tretinoin—Erythema—Docetaxel—melanoma	0.00022	0.000663	CcSEcCtD
Tretinoin—Hypersensitivity—Dactinomycin—melanoma	0.00022	0.000662	CcSEcCtD
Tretinoin—Urticaria—Temozolomide—melanoma	0.000215	0.000646	CcSEcCtD
Tretinoin—Asthenia—Dactinomycin—melanoma	0.000214	0.000645	CcSEcCtD
Tretinoin—Body temperature increased—Temozolomide—melanoma	0.000214	0.000643	CcSEcCtD
Tretinoin—Abdominal pain—Temozolomide—melanoma	0.000214	0.000643	CcSEcCtD
Tretinoin—Back pain—Docetaxel—melanoma	0.000213	0.000641	CcSEcCtD
Tretinoin—Hypersensitivity—Carmustine—melanoma	0.000206	0.00062	CcSEcCtD
Tretinoin—Diarrhoea—Dactinomycin—melanoma	0.000204	0.000615	CcSEcCtD
Tretinoin—Vomiting—Bleomycin—melanoma	0.000204	0.000613	CcSEcCtD
Tretinoin—Anaemia—Docetaxel—melanoma	0.000204	0.000612	CcSEcCtD
Tretinoin—Rash—Bleomycin—melanoma	0.000202	0.000608	CcSEcCtD
Tretinoin—Dermatitis—Bleomycin—melanoma	0.000202	0.000607	CcSEcCtD
Tretinoin—Asthenia—Carmustine—melanoma	0.000201	0.000604	CcSEcCtD
Tretinoin—Hypersensitivity—Temozolomide—melanoma	0.000199	0.000599	CcSEcCtD
Tretinoin—Syncope—Docetaxel—melanoma	0.000198	0.000594	CcSEcCtD
Tretinoin—Palpitations—Docetaxel—melanoma	0.000195	0.000586	CcSEcCtD
Tretinoin—Asthenia—Temozolomide—melanoma	0.000194	0.000583	CcSEcCtD
Tretinoin—Loss of consciousness—Docetaxel—melanoma	0.000194	0.000582	CcSEcCtD
Tretinoin—Cough—Docetaxel—melanoma	0.000192	0.000578	CcSEcCtD
Tretinoin—Diarrhoea—Carmustine—melanoma	0.000191	0.000576	CcSEcCtD
Tretinoin—Pruritus—Temozolomide—melanoma	0.000191	0.000575	CcSEcCtD
Tretinoin—Convulsion—Docetaxel—melanoma	0.000191	0.000574	CcSEcCtD
Tretinoin—Nausea—Bleomycin—melanoma	0.00019	0.000573	CcSEcCtD
Tretinoin—Hypertension—Docetaxel—melanoma	0.00019	0.000572	CcSEcCtD
Tretinoin—Vomiting—Dactinomycin—melanoma	0.00019	0.000572	CcSEcCtD
Tretinoin—Rash—Dactinomycin—melanoma	0.000188	0.000567	CcSEcCtD
Tretinoin—Arthralgia—Docetaxel—melanoma	0.000188	0.000564	CcSEcCtD
Tretinoin—Myalgia—Docetaxel—melanoma	0.000188	0.000564	CcSEcCtD
Tretinoin—Chest pain—Docetaxel—melanoma	0.000188	0.000564	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000186	0.00056	CcSEcCtD
Tretinoin—Dizziness—Carmustine—melanoma	0.000185	0.000556	CcSEcCtD
Tretinoin—Diarrhoea—Temozolomide—melanoma	0.000185	0.000556	CcSEcCtD
Tretinoin—Dry mouth—Docetaxel—melanoma	0.000183	0.000552	CcSEcCtD
Tretinoin—Confusional state—Docetaxel—melanoma	0.000181	0.000545	CcSEcCtD
Tretinoin—Oedema—Docetaxel—melanoma	0.00018	0.000541	CcSEcCtD
Tretinoin—Anaphylactic shock—Docetaxel—melanoma	0.00018	0.000541	CcSEcCtD
Tretinoin—Dizziness—Temozolomide—melanoma	0.000179	0.000538	CcSEcCtD
Tretinoin—Infection—Docetaxel—melanoma	0.000179	0.000537	CcSEcCtD
Tretinoin—Vomiting—Carmustine—melanoma	0.000178	0.000535	CcSEcCtD
Tretinoin—Nausea—Dactinomycin—melanoma	0.000178	0.000534	CcSEcCtD
Tretinoin—Shock—Docetaxel—melanoma	0.000177	0.000532	CcSEcCtD
Tretinoin—Rash—Carmustine—melanoma	0.000176	0.000531	CcSEcCtD
Tretinoin—Nervous system disorder—Docetaxel—melanoma	0.000176	0.00053	CcSEcCtD
Tretinoin—Dermatitis—Carmustine—melanoma	0.000176	0.00053	CcSEcCtD
Tretinoin—Thrombocytopenia—Docetaxel—melanoma	0.000176	0.00053	CcSEcCtD
Tretinoin—Tachycardia—Docetaxel—melanoma	0.000175	0.000528	CcSEcCtD
Tretinoin—Headache—Carmustine—melanoma	0.000175	0.000527	CcSEcCtD
Tretinoin—Skin disorder—Docetaxel—melanoma	0.000175	0.000525	CcSEcCtD
Tretinoin—Vomiting—Temozolomide—melanoma	0.000172	0.000517	CcSEcCtD
Tretinoin—Anorexia—Docetaxel—melanoma	0.000171	0.000516	CcSEcCtD
Tretinoin—Rash—Temozolomide—melanoma	0.00017	0.000513	CcSEcCtD
Tretinoin—Dermatitis—Temozolomide—melanoma	0.00017	0.000512	CcSEcCtD
Tretinoin—Headache—Temozolomide—melanoma	0.000169	0.000509	CcSEcCtD
Tretinoin—Hypotension—Docetaxel—melanoma	0.000168	0.000505	CcSEcCtD
Tretinoin—Nausea—Carmustine—melanoma	0.000166	0.0005	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000164	0.000493	CcSEcCtD
Tretinoin—Insomnia—Docetaxel—melanoma	0.000163	0.000489	CcSEcCtD
Tretinoin—Paraesthesia—Docetaxel—melanoma	0.000161	0.000486	CcSEcCtD
Tretinoin—Nausea—Temozolomide—melanoma	0.000161	0.000483	CcSEcCtD
Tretinoin—Dyspnoea—Docetaxel—melanoma	0.00016	0.000482	CcSEcCtD
Tretinoin—Somnolence—Docetaxel—melanoma	0.00016	0.000481	CcSEcCtD
Tretinoin—Dyspepsia—Docetaxel—melanoma	0.000158	0.000476	CcSEcCtD
Tretinoin—Decreased appetite—Docetaxel—melanoma	0.000156	0.00047	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Docetaxel—melanoma	0.000155	0.000467	CcSEcCtD
Tretinoin—Fatigue—Docetaxel—melanoma	0.000155	0.000466	CcSEcCtD
Tretinoin—Pain—Docetaxel—melanoma	0.000154	0.000462	CcSEcCtD
Tretinoin—Constipation—Docetaxel—melanoma	0.000154	0.000462	CcSEcCtD
Tretinoin—Feeling abnormal—Docetaxel—melanoma	0.000148	0.000446	CcSEcCtD
Tretinoin—Gastrointestinal pain—Docetaxel—melanoma	0.000147	0.000442	CcSEcCtD
Tretinoin—Abdominal pain—Docetaxel—melanoma	0.000142	0.000428	CcSEcCtD
Tretinoin—Body temperature increased—Docetaxel—melanoma	0.000142	0.000428	CcSEcCtD
Tretinoin—Hypersensitivity—Docetaxel—melanoma	0.000132	0.000398	CcSEcCtD
Tretinoin—Asthenia—Docetaxel—melanoma	0.000129	0.000388	CcSEcCtD
Tretinoin—Pruritus—Docetaxel—melanoma	0.000127	0.000383	CcSEcCtD
Tretinoin—Diarrhoea—Docetaxel—melanoma	0.000123	0.00037	CcSEcCtD
Tretinoin—Dizziness—Docetaxel—melanoma	0.000119	0.000358	CcSEcCtD
Tretinoin—Vomiting—Docetaxel—melanoma	0.000114	0.000344	CcSEcCtD
Tretinoin—Rash—Docetaxel—melanoma	0.000113	0.000341	CcSEcCtD
Tretinoin—Dermatitis—Docetaxel—melanoma	0.000113	0.000341	CcSEcCtD
Tretinoin—Headache—Docetaxel—melanoma	0.000113	0.000339	CcSEcCtD
Tretinoin—Nausea—Docetaxel—melanoma	0.000107	0.000321	CcSEcCtD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.5e-05	5.44e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PLA2G6—melanoma	1.5e-05	5.43e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—NOTCH1—melanoma	1.49e-05	5.41e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—TNF—melanoma	1.46e-05	5.3e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PHGDH—melanoma	1.46e-05	5.3e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—LUM—melanoma	1.46e-05	5.3e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GNAQ—melanoma	1.46e-05	5.29e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CD44—melanoma	1.46e-05	5.29e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—VCAN—melanoma	1.46e-05	5.29e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—KRAS—melanoma	1.45e-05	5.26e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PRKCA—melanoma	1.45e-05	5.25e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GNA11—melanoma	1.44e-05	5.22e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ERCC2—melanoma	1.44e-05	5.21e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—HPSE—melanoma	1.43e-05	5.19e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PIK3CG—melanoma	1.43e-05	5.19e-05	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—AKT1—melanoma	1.43e-05	5.18e-05	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—AKT1—melanoma	1.43e-05	5.18e-05	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—AKT1—melanoma	1.43e-05	5.18e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—VCAN—melanoma	1.43e-05	5.17e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—FASN—melanoma	1.41e-05	5.11e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—PPARG—melanoma	1.41e-05	5.1e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CUBN—melanoma	1.41e-05	5.1e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CYP1B1—melanoma	1.4e-05	5.08e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—SLC5A5—melanoma	1.39e-05	5.02e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PPARG—melanoma	1.38e-05	5e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PLA2G6—melanoma	1.38e-05	4.98e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SDHD—melanoma	1.36e-05	4.92e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CSPG4—melanoma	1.36e-05	4.92e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—BSG—melanoma	1.36e-05	4.92e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—VCAN—melanoma	1.35e-05	4.88e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GNAQ—melanoma	1.34e-05	4.85e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CD44—melanoma	1.34e-05	4.85e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GPAM—melanoma	1.32e-05	4.77e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CYP1B1—melanoma	1.29e-05	4.65e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.28e-05	4.62e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PIK3CD—melanoma	1.26e-05	4.56e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3CG—melanoma	1.25e-05	4.53e-05	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—AKT1—melanoma	1.24e-05	4.5e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—ALB—melanoma	1.24e-05	4.5e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—VCAN—melanoma	1.24e-05	4.48e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—HRAS—melanoma	1.23e-05	4.47e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP17A1—melanoma	1.23e-05	4.46e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.23e-05	4.46e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PPARG—melanoma	1.21e-05	4.37e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP17A1—melanoma	1.2e-05	4.36e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.19e-05	4.31e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PLCB4—melanoma	1.18e-05	4.28e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—IL6—melanoma	1.18e-05	4.28e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.17e-05	4.24e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GNA11—melanoma	1.16e-05	4.21e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ABCB1—melanoma	1.15e-05	4.18e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—FASN—melanoma	1.14e-05	4.12e-05	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—AKT1—melanoma	1.14e-05	4.12e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP17A1—melanoma	1.14e-05	4.12e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GNA11—melanoma	1.14e-05	4.12e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CG—melanoma	1.14e-05	4.11e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.13e-05	4.09e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.12e-05	4.06e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PLA2G6—melanoma	1.12e-05	4.05e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—SLC5A5—melanoma	1.12e-05	4.05e-05	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—AKT1—melanoma	1.12e-05	4.04e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC6A11—melanoma	1.11e-05	4.03e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIP4K2A—melanoma	1.11e-05	4.03e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—FASN—melanoma	1.11e-05	4.03e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—melanoma	1.11e-05	4.01e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3CD—melanoma	1.1e-05	3.98e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PIK3CB—melanoma	1.1e-05	3.97e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PPARG—melanoma	1.1e-05	3.97e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—SLC5A5—melanoma	1.09e-05	3.96e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—AKT1—melanoma	1.09e-05	3.95e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PTGS2—melanoma	1.09e-05	3.94e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—ALB—melanoma	1.09e-05	3.93e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—MTAP—melanoma	1.08e-05	3.92e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GNAQ—melanoma	1.08e-05	3.92e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CD44—melanoma	1.08e-05	3.92e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GNA11—melanoma	1.07e-05	3.89e-05	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—AKT1—melanoma	1.07e-05	3.87e-05	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—AKT1—melanoma	1.07e-05	3.87e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PRKCA—melanoma	1.06e-05	3.85e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ABCB1—melanoma	1.06e-05	3.83e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GNAQ—melanoma	1.06e-05	3.83e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CD44—melanoma	1.06e-05	3.83e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ERCC2—melanoma	1.05e-05	3.82e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—FASN—melanoma	1.05e-05	3.81e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP17A1—melanoma	1.04e-05	3.78e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP1B1—melanoma	1.04e-05	3.75e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—SLC5A5—melanoma	1.03e-05	3.74e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.03e-05	3.72e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	1.02e-05	3.68e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP1B1—melanoma	1.01e-05	3.67e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—VCAN—melanoma	1.01e-05	3.64e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GNAQ—melanoma	9.99e-06	3.62e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CD44—melanoma	9.99e-06	3.62e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CD—melanoma	9.99e-06	3.62e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ALB—melanoma	9.86e-06	3.57e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GNA11—melanoma	9.85e-06	3.57e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.78e-06	3.54e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PRKCA—melanoma	9.74e-06	3.53e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.69e-06	3.51e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ERCC2—melanoma	9.66e-06	3.5e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—LUM—melanoma	9.65e-06	3.49e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PHGDH—melanoma	9.65e-06	3.49e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—FASN—melanoma	9.64e-06	3.49e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3CB—melanoma	9.59e-06	3.47e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP1B1—melanoma	9.57e-06	3.47e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.52e-06	3.45e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTGS2—melanoma	9.5e-06	3.44e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PTEN—melanoma	9.48e-06	3.43e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SLC5A5—melanoma	9.48e-06	3.43e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HPSE—melanoma	9.46e-06	3.43e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CUBN—melanoma	9.29e-06	3.36e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.19e-06	3.33e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CD44—melanoma	9.16e-06	3.31e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GNAQ—melanoma	9.16e-06	3.31e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SDHD—melanoma	8.97e-06	3.25e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CSPG4—melanoma	8.97e-06	3.25e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—BSG—melanoma	8.97e-06	3.25e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.97e-06	3.25e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.88e-06	3.22e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP1B1—melanoma	8.78e-06	3.18e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CB—melanoma	8.7e-06	3.15e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GPAM—melanoma	8.69e-06	3.15e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTGS2—melanoma	8.62e-06	3.12e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ABCB1—melanoma	8.54e-06	3.09e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP17A1—melanoma	8.49e-06	3.07e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.45e-06	3.06e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.37e-06	3.03e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ABCB1—melanoma	8.35e-06	3.02e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CG—melanoma	8.32e-06	3.01e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTEN—melanoma	8.29e-06	3e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—MAPK3—melanoma	8.26e-06	2.99e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	8.26e-06	2.99e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—MYC—melanoma	8.04e-06	2.91e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PPARG—melanoma	8.03e-06	2.91e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GNA11—melanoma	8.02e-06	2.9e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ABCB1—melanoma	7.88e-06	2.85e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PRKCA—melanoma	7.86e-06	2.85e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—FASN—melanoma	7.84e-06	2.84e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ERCC2—melanoma	7.79e-06	2.82e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.75e-06	2.8e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SLC5A5—melanoma	7.72e-06	2.79e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PRKCA—melanoma	7.68e-06	2.78e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CG—melanoma	7.63e-06	2.76e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ERCC2—melanoma	7.62e-06	2.76e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTEN—melanoma	7.52e-06	2.72e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GNAQ—melanoma	7.45e-06	2.7e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CD44—melanoma	7.45e-06	2.7e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PLA2G6—melanoma	7.39e-06	2.67e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PPARG—melanoma	7.36e-06	2.67e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CD—melanoma	7.32e-06	2.65e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.3e-06	2.64e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PRKCA—melanoma	7.26e-06	2.63e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.23e-06	2.62e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ABCB1—melanoma	7.23e-06	2.62e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ALB—melanoma	7.22e-06	2.61e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ERCC2—melanoma	7.2e-06	2.61e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP1B1—melanoma	7.14e-06	2.59e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CD—melanoma	6.71e-06	2.43e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PIK3CA—melanoma	6.69e-06	2.42e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PRKCA—melanoma	6.65e-06	2.41e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—VCAN—melanoma	6.63e-06	2.4e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ALB—melanoma	6.62e-06	2.4e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ERCC2—melanoma	6.6e-06	2.39e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CB—melanoma	6.38e-06	2.31e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTGS2—melanoma	6.32e-06	2.29e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.3e-06	2.28e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CG—melanoma	6.15e-06	2.23e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CG—melanoma	6.02e-06	2.18e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.96e-06	2.16e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PPARG—melanoma	5.94e-06	2.15e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ABCB1—melanoma	5.88e-06	2.13e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3CA—melanoma	5.85e-06	2.12e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CB—melanoma	5.85e-06	2.12e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PPARG—melanoma	5.81e-06	2.1e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTGS2—melanoma	5.79e-06	2.1e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CG—melanoma	5.68e-06	2.06e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP17A1—melanoma	5.6e-06	2.03e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—AKT1—melanoma	5.57e-06	2.02e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTEN—melanoma	5.51e-06	2e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PPARG—melanoma	5.49e-06	1.99e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.47e-06	1.98e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—AKT1—melanoma	5.47e-06	1.98e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PRKCA—melanoma	5.41e-06	1.96e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CD—melanoma	5.41e-06	1.96e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ERCC2—melanoma	5.37e-06	1.94e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ALB—melanoma	5.34e-06	1.93e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CA—melanoma	5.31e-06	1.92e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CD—melanoma	5.29e-06	1.91e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GNA11—melanoma	5.29e-06	1.91e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ALB—melanoma	5.22e-06	1.89e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CG—melanoma	5.21e-06	1.89e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—FASN—melanoma	5.17e-06	1.87e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC5A5—melanoma	5.09e-06	1.84e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTEN—melanoma	5.05e-06	1.83e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PPARG—melanoma	5.03e-06	1.82e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CD—melanoma	5e-06	1.81e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ALB—melanoma	4.93e-06	1.79e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GNAQ—melanoma	4.91e-06	1.78e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CD44—melanoma	4.91e-06	1.78e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—AKT1—melanoma	4.78e-06	1.73e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CB—melanoma	4.72e-06	1.71e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP1B1—melanoma	4.71e-06	1.71e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTGS2—melanoma	4.67e-06	1.69e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CB—melanoma	4.61e-06	1.67e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CD—melanoma	4.58e-06	1.66e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTGS2—melanoma	4.57e-06	1.65e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ALB—melanoma	4.52e-06	1.64e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.45e-06	1.61e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CB—melanoma	4.35e-06	1.58e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—AKT1—melanoma	4.33e-06	1.57e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTGS2—melanoma	4.32e-06	1.56e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CG—melanoma	4.24e-06	1.54e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PPARG—melanoma	4.09e-06	1.48e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTEN—melanoma	4.08e-06	1.48e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CB—melanoma	3.99e-06	1.45e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTEN—melanoma	3.98e-06	1.44e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTGS2—melanoma	3.96e-06	1.43e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CA—melanoma	3.89e-06	1.41e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ABCB1—melanoma	3.88e-06	1.4e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTEN—melanoma	3.76e-06	1.36e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CD—melanoma	3.73e-06	1.35e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALB—melanoma	3.68e-06	1.33e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PRKCA—melanoma	3.57e-06	1.29e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CA—melanoma	3.56e-06	1.29e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ERCC2—melanoma	3.54e-06	1.28e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTEN—melanoma	3.45e-06	1.25e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CB—melanoma	3.25e-06	1.18e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTGS2—melanoma	3.22e-06	1.17e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—AKT1—melanoma	3.18e-06	1.15e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—AKT1—melanoma	2.91e-06	1.05e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CA—melanoma	2.87e-06	1.04e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CA—melanoma	2.81e-06	1.02e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTEN—melanoma	2.81e-06	1.02e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CG—melanoma	2.8e-06	1.01e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PPARG—melanoma	2.7e-06	9.77e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CA—melanoma	2.65e-06	9.61e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CD—melanoma	2.46e-06	8.9e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CA—melanoma	2.43e-06	8.81e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALB—melanoma	2.43e-06	8.79e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—AKT1—melanoma	2.35e-06	8.5e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—AKT1—melanoma	2.3e-06	8.31e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—AKT1—melanoma	2.17e-06	7.85e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CB—melanoma	2.14e-06	7.76e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTGS2—melanoma	2.12e-06	7.69e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—AKT1—melanoma	1.99e-06	7.2e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CA—melanoma	1.98e-06	7.17e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTEN—melanoma	1.85e-06	6.7e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—AKT1—melanoma	1.62e-06	5.86e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CA—melanoma	1.31e-06	4.73e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AKT1—melanoma	1.07e-06	3.86e-06	CbGpPWpGaD
